Cargando…
Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hydrophilic/lipophilic emulsions and liposomes. In t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272979/ https://www.ncbi.nlm.nih.gov/pubmed/27367664 http://dx.doi.org/10.3390/molecules21070858 |
_version_ | 1783377278631149568 |
---|---|
author | Ochiuz, Lacramioara Grigoras, Cristian Popa, Marcel Stoleriu, Iulian Munteanu, Corneliu Timofte, Daniel Profire, Lenuta Grigoras, Anca Giorgiana |
author_facet | Ochiuz, Lacramioara Grigoras, Cristian Popa, Marcel Stoleriu, Iulian Munteanu, Corneliu Timofte, Daniel Profire, Lenuta Grigoras, Anca Giorgiana |
author_sort | Ochiuz, Lacramioara |
collection | PubMed |
description | The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hydrophilic/lipophilic emulsions and liposomes. In the current study, we present our most recent advances in the preparation of alendronate (AL)-loaded SLPs prepared by hot homogenization and ultrasonication using various ratios of a self-emulsifying lipidic mixture of Compritol 888, Gelucire 44/14, and Cremophor A 25. The prepared AL-loaded SLPs were investigated for their physicochemical, morphological and structural characteristics by dynamic light scattering, differential scanning calorimetry, thermogravimetric and powder X-ray diffraction analysis, infrared spectroscopy, optical and scanning electron microscopy. Entrapment efficacy and actual drug content were assessed by a validated HPLC method. In vitro dissolution tests performed in simulated gastro-intestinal fluids and phosphate buffer solution pH 7.4 revealed a prolonged release of AL of 70 h. Additionally, release kinetics analysis showed that both in simulated gastrointestinal fluids and in phosphate buffer solution, AL is released from SLPs based on equal ratios of lipid excipients following zero-order kinetics, which characterizes prolonged-release drug systems. |
format | Online Article Text |
id | pubmed-6272979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62729792018-12-28 Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration Ochiuz, Lacramioara Grigoras, Cristian Popa, Marcel Stoleriu, Iulian Munteanu, Corneliu Timofte, Daniel Profire, Lenuta Grigoras, Anca Giorgiana Molecules Article The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hydrophilic/lipophilic emulsions and liposomes. In the current study, we present our most recent advances in the preparation of alendronate (AL)-loaded SLPs prepared by hot homogenization and ultrasonication using various ratios of a self-emulsifying lipidic mixture of Compritol 888, Gelucire 44/14, and Cremophor A 25. The prepared AL-loaded SLPs were investigated for their physicochemical, morphological and structural characteristics by dynamic light scattering, differential scanning calorimetry, thermogravimetric and powder X-ray diffraction analysis, infrared spectroscopy, optical and scanning electron microscopy. Entrapment efficacy and actual drug content were assessed by a validated HPLC method. In vitro dissolution tests performed in simulated gastro-intestinal fluids and phosphate buffer solution pH 7.4 revealed a prolonged release of AL of 70 h. Additionally, release kinetics analysis showed that both in simulated gastrointestinal fluids and in phosphate buffer solution, AL is released from SLPs based on equal ratios of lipid excipients following zero-order kinetics, which characterizes prolonged-release drug systems. MDPI 2016-06-29 /pmc/articles/PMC6272979/ /pubmed/27367664 http://dx.doi.org/10.3390/molecules21070858 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ochiuz, Lacramioara Grigoras, Cristian Popa, Marcel Stoleriu, Iulian Munteanu, Corneliu Timofte, Daniel Profire, Lenuta Grigoras, Anca Giorgiana Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration |
title | Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration |
title_full | Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration |
title_fullStr | Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration |
title_full_unstemmed | Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration |
title_short | Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration |
title_sort | alendronate-loaded modified drug delivery lipid particles intended for improved oral and topical administration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272979/ https://www.ncbi.nlm.nih.gov/pubmed/27367664 http://dx.doi.org/10.3390/molecules21070858 |
work_keys_str_mv | AT ochiuzlacramioara alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration AT grigorascristian alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration AT popamarcel alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration AT stoleriuiulian alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration AT munteanucorneliu alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration AT timoftedaniel alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration AT profirelenuta alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration AT grigorasancagiorgiana alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration |